BREITMEYER JAMES B (President, CEO) reported 2 transactions at ONCTERNAL THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 7/5/2023ACC: 0001209191-23-041319
DirectorOfficer· President, CEO
Since Jun 2019
-52K
Net shares
Net seller
$18.7K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
52K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−47.99K
Price / share
$0.36
Trade value
$17.28K
% of position
8.9%
7/3/2023
541.98K→493.99K
Common Stock
Indirect
Shares
−4.01K
Price / share
$0.36
Trade value
$1.44K
% of position
16.8%
7/3/2023
23.92K→19.91K
Total
Net shares
−52K
Net value
-$18.72K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/3/2023 | F · Tax Withholding | −47.99K | $0.36 | $17.28K | 8.9% | 541.98K | 493.99K |
| Common Stock Indirect | 7/3/2023 | F · Tax Withholding | −4.01K | $0.36 | $1.44K | 16.8% | 23.92K | 19.91K |
| Total | −52K | -$18.72K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned196.54K
Common Stock
IndirectShares owned733.00
Total
197.28K indirect197.28K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 196.54K | Indirect |
| Common Stock | 733.00 | Indirect |
| Total | 197.28K | 197.28K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported